UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) AND METALLOPROTEINASE (MMP-2 AND MMPì9) MAY REPRESENT SIGNIFICANT DIAGNOSTIC AND PROGNOSTIC MARKERS IN HUMAN PROSTATIC CANCER.